C. Patrick

6.6k citations

50 papers · 1.4k indexed · 2 hit papers · h-index 13

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Cancer Research top 10%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Pulmonary and Respiratory Medicine 32
- Lung Cancer Treatments and Mutations 26
Oncology 32
- Cancer Immunotherapy and Biomarkers 14
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 8

Co-authors: Zuan-Fu Lim (4 shared papers)Daniel Morgensztern (3 shared papers)Corey A. Carter (1 shared paper)Bryan Oronsky (2 shared papers)Alexander I. Spira (7 shared papers)Stephen V. Liu (23 shared papers)Ari M. Vanderwalde (14 shared papers)Jorge J. Nieva (10 shared papers)
Journals: Journal of Clinical Oncology (22 papers)Cancer Research (4 papers)Translational Lung Cancer Research (2 papers)Clinical Cancer Research (1 paper)Neoplasia (1 paper)
Partner nations: United States Austria South Korea

In The Last Decade

C. Patrick

46 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy 2019 · 414 citations

Peers

Countries citing papers authored by C. Patrick

Since Specialization

Citations

This map shows the geographic impact of C. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Patrick more than expected).

Fields of papers citing papers by C. Patrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Patrick. The network helps show where C. Patrick may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Patrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Patrick Line = papers co-authored together C. Patrick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas Neoplasia ·Bryan Oronsky, C. Patrick, Daniel Morgensztern, Corey A. Carter Hit paper breakdown →	2017	437
2	Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy Journal of Hematology & Oncology ·Zuan-Fu Lim, C. Patrick Hit paper breakdown →	2019	414
3	Detection of NRG1 Gene Fusions in Solid Tumors Clinical Cancer Research ·Sushma Jonna, Rebecca Feldman, Jeffrey Swensen, Zoran Gatalica, W. Michael Korn, Hossein Borghaei, C. Patrick, Jorge J. Nieva, Alexander I. Spira, Ari M. Vanderwalde, Antoinette J. Wozniak, Edward S. Kim, Stephen V. Liu	2019	155
4	Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not? Cancers ·Heidar Albandar, Jacob Fuqua, Jasim M. Albandar, Salahuddin Safi, Samuel A. Merrill, C. Patrick	2021	44
5	RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer British Journal of Cancer ·Daniel Morgensztern, Michal G. Rose, Saiama N. Waqar, John C. Morris, C. Patrick, Thomas Reid, Christina Brzezniak, Karen Zeman, Arvinda Padmanabhan, JoAnn Hirth, Alexander I. Spira, Jane B. Trepel, Sukhmani K. Padda	2019	37
6	Y Chromosome LncRNA Are Involved in Radiation Response of Male Non–Small Cell Lung Cancer Cells Cancer Research ·Tayvia Brownmiller, Jamie A. Juric, Abby D. Ivey, Brandon M. Harvey, Emily S. Westemeier, Michael T. Winters, Alyson M. Stevens, Alana N. Stanley, Karen E. Hayes, Samuel A. Sprowls, Amanda S. Gatesman Ammer, Mackenzee Walker, Erik A. Bey, WU Xiao-liang, Zuan-Fu Lim, Lin Zhu, Sijin Wen, Gangqing Hu, C. Patrick, Iván Martínez	2020	35
7	AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases Journal of Cancer Research and Clinical Oncology ·Xiaoliang Wu, Wenjuan Ma, Qianghua Zhou, Haijuan Yan, Zuan-Fu Lim, Mayan Huang, Chuangzhong Deng, Xingsu Yu, Huifang Su, Satoshi Komo, Haixia Yang, Xinke Zhang, Sijin Wen, Zhenfeng Zhang, C. Patrick	2017	32
8	MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies Expert Opinion on Therapeutic Targets ·Matthew Lee, Prantesh Jain, Feng Wang, C. Patrick, Alain Borczuk, Balázs Halmos	2021	27
9	A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non–Small Cell Lung Cancer Clinical Lung Cancer ·Malcolm D. Mattes, Timothy D. Eubank, Mohammed Almubarak, Sijin Wen, Gary Marano, Geraldine M. Jacobson, C. Patrick	2021	21
10	Developing strategies to manage highly phosphine resistant populations of flat grain beetles in large bulk storages in Australia Federal Research Centre for Cultivated Plants (Julius Kühn-Institut) ·Manoj K. Nayak, Joanne C. Holloway, Hervoika Pavic, Mickey P. Head, Richard C. Reid, C. Patrick	2010	20
11	Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing JTO Clinical and Research Reports ·So Yeon Kim, Jun‐Jie Yin, Stephen Bohlman, Phillip Walker, Sanja Đačić, Chul Kim, Hina Khan, Stephen V. Liu, C. Patrick, Misako Nagasaka, Karen L. Reckamp, Jim Abraham, Dipesh Uprety, Feng Wang, Joanne Xiu, Jian Zhang, Haiying Cheng, Balázs Halmos	2022	13
12	Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura Case Reports in Oncology ·James T. Boothe, G. Thomas Budd, Matthew B. Smolkin, C. Patrick	2017	12
13	c-MET expression/activation, functions, and mutations in non-small cell lung cancer C. Patrick, Simha Jagadeesh, Ramasamy Jagadeeswaran, Edward A. Fox, James Christensen, Gautam Maulik, Katsuhiko Naoki, Erik Schaefer, Alan S. Lader, William G. Richards, David J. Sugarbaker, Matthew Meyerson, Ravi Salgia	2004	12
14	Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers Nature Cancer ·Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S. El‐Deiry, Emmanuel S. Antonarakis, Stephanie L. Graff, Michael J. Hall, Hossein Borghaei, Dave S.�B. Hoon, Stephen V. Liu, C. Patrick, Rana R. McKay, Trisha M. Wise‐Draper, John L. Marshall, George W. Sledge, David Spetzler, Hao Zhu, David Hsiehchen	2024	11
15	SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Cancer Research ·Utsav Sen, Charles Coleman, Nishant Gandhi, Vrinda Jethalia, Deniz Demircioğlu, Andrew Elliott, Ari M. Vanderwalde, Omar Hayatt, Elisa de Stanchina, Balázs Halmos, C. Patrick, Mirela Berisa, Dan Hasson, Triparna Sen	2025	11
16	Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC Theranostics ·Yayi He, Linsong Chen, Lishu Zhao, Shiying Dang, Guifeng Liu, Shinji Sasada, C. Patrick, Nico van Zandwijk, Rafael Rosell, Helmut Popper, Hao Wang, Minlin Jiang, Haoyue Guo, Xinyi Liu, Shifu Chen, Xiaoni Zhang, Mingyan Xu, Bo Zhu, Ming Liu, Caicun Zhou	2021	11
17	DNA damage response and repair (DDR) gene mutations and correlation with tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Hirva Mamdani, Jerry Yongqiang Chen, Seongho Kim, Yahya Ibrahim, Mohammad Asad, Jorge J. Nieva, Rebecca Feldman, Abdul Rafeh Naqash, Stephen V. Liu, C. Patrick, David C. Portnoy, Hossein Borghaei, Nagla Fawzy Abdel Karim, Yanis Boumber, Ari M. Vanderwalde, Alexander I. Spira, Shadia I. Jalal	2019	11
18	Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non–Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib Clinical Chemistry ·Todd Hembrough, Wei-Li Liao, Christopher Hartley, C. Patrick, Vamsidhar Velcheti, Christopher Lanigan, Sheeno Thyparambil, Eunkyung An, Manish Monga, David B. Krizman, Jon Burrows, Laura J. Tafe	2015	10
19	Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung. Journal of Clinical Oncology ·Chul Kim, Julie McGrath, Joanne Xiu, Misako Nagasaka, C. Patrick, Jorge J. Nieva, Gilberto Lopes, Hossein Borghaei, Chukwuemeka Ikpeazu, Taofeek K. Owonikoko, Michael J. Demeure, Antoinette J. Wozniak, Chadi Nabhan, W. Michael Korn, Stephen V. Liu	2021	8
20	Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors The Oncologist ·Dan Morgenstern‐Kaplan, Samuel A. Kareff, Asaad Trabolsi, Estelamari Rodríguez, Harris B. Krause, Jennifer R. Ribeiro, Heng Tan, Emmanuel S. Antonarakis, Emil Lou, Misako Nagasaka, Sandra Algaze, Heinz‐Josef Lenz, Stephen V. Liu, Balázs Halmos, Dave S.�B. Hoon, Peter A. Seeber, C. Patrick, Wafik S. El‐Deiry, Ari M. Vanderwalde, Gilberto Lopes	2024	7

About C. Patrick

C. Patrick is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (26 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (14 papers), Lung Cancer Research Studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers), RNA modifications and cancer (4 papers), Genetic factors in colorectal cancer (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (781 citations), Cancer Research (267 citations), Neurology (267 citations), Epidemiology (442 citations) and Pulmonary and Respiratory Medicine (368 citations). C. Patrick has collaborated with scholars based in United States, Austria and South Korea. Frequent co-authors include Zuan-Fu Lim, Daniel Morgensztern, Corey A. Carter, Bryan Oronsky, Alexander I. Spira, Stephen V. Liu, Ari M. Vanderwalde, Jorge J. Nieva, Hossein Borghaei and Rebecca Feldman. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Translational Lung Cancer Research, Clinical Cancer Research and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact